Service de Chirurgie Thoracique Nouvel Hôpital Civil Hôpitaux Universitaires de Strasbourg
Strasbourg, 67091, France
NCT Number: NCT04446286
Describes the cohort of patients receiving ECMO-VV or ECMO-VA in the management of severe ARDS refractory to SARS-CoV-2 in the Strasbourg and Louvain centres
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Strasbourg, 67091, France
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: files analysed retrospectily from March 1st, 2020 to August 1st, 2020 will be examined
University Hospital, Strasbourg, France
Other
Acronym: ECMO-SL-CoV-2
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04444609
ARDS, Human, COVID-19
London, United Kingdom
View Trial DetailsNCT04402879
ARDS, Acute Respiratory Distress Syndrome
Calgary, Alberta, Canada
View Trial DetailsNCT07466524
Acute Respiratory Distress Syndrome, COVID-19
Ann Arbor, Michigan, United States
View Trial DetailsNCT04316884
Acute Kidney Injury, Acute Respiratory Distress Syndrome
Uppsala, Uppsala County, Sweden
View Trial Details